China SXT Pharmaceuticals Inc. logo

China SXT Pharmaceuticals Inc.

SXTC | NASDAQ
Chart Builder DCF Calculator
$2.47
+$0.09 (+3.78%)
At close: Sep 22, 2026, 4:00 PM ET
$2.45
-$0.02 (-0.81%)
After-hours: Sep 22, 2026, 7:48 PM ET

Company Profile

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Key Executives

Name Position
Feng Zhou Chairman of the Board & Co-CEO
Sze Beng Lim Co-Chief Executive Officer
Xiaodong Pan Chief Financial Officer
Jun Zheng Executive Director

Latest SEC Filings

Date Type Title
Aug 28, 2026 F-3/A [Amend] Filing
Aug 28, 2026 6-K Filing
Jul 24, 2026 6-K Filing
Jul 24, 2026 424B5 Filing
Jul 07, 2026 F-3 Filing
Jul 06, 2026 6-K Filing
Jul 01, 2026 20-F Filing
Jun 01, 2026 6-K Filing
Jun 01, 2026 424B5 Filing
May 04, 2026 6-K Filing
View All SEC Filings
China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc. logo
Country China
IPO Date Jan 3, 2019
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 56
CEO Feng Zhou

Contact Details

178 Taidong Road North Taizhou, JS 225300 China

Stock Details

Ticker Symbol SXTC
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001723980
CUSIP Number G2161P165
ISIN Number VGG2161P1734
SIC Code 2834

© 2026 bestshares.com. All rights reserved.